Summit Pharmaceuticals International Corp. to serve as exclusive distributor for cell culture supplements in Japanese Market.The agreement marks ...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has issued a Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS (GMP ...
AACHEN, Germany, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion ...
Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology from ...
New high-quality cell growth supplement for cell manufacturing applications including in regenerative medicine and cell therapies Human Platelet Lysate (HPL) offers a safer and sustainable alternative ...
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- AVANT BIO LLC, a pioneering growth equity firm, has announced Avant Bio Fund II LP's participation in a series of key financing rounds, reinforcing its mission ...
PL BioScience GmbH, a life science company located in Aachen, Germany, specializes in the production and development of Human Platelet Lysate (HPL). The Company has pioneered proprietary technology to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results